CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
30 juil. 2024 02h00 HE
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
29 juil. 2024 08h00 HE
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
Global Commercial Aviation Market to register a CAGR of 7.65% during 2023 - 2028 - Market Size, Share, Forecasts & Trends Analysis Report by Mordor Intelligence
16 mars 2023 09h00 HE
|
Mordor Intelligence
Hyderabad, March 16, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “Global Commercial Aviation Market Share (2023-2028)”, the commercial aviation industry is expected to...
Aprea Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of Oral ATR Inhibitor ATRN-119 for the Treatment of Advanced Solid Tumors
11 janv. 2023 08h00 HE
|
Aprea Therapeutics
DOYLESTOWN, Pa., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics...
Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations
09 nov. 2022 16h15 HE
|
Aprea Therapeutics
BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel synthetic lethality-based cancer...
Aprea Therapeutics to Participate in the 2022 H.C. Wainwright Global Investment Conference
08 sept. 2022 08h00 HE
|
Aprea Therapeutics
BOSTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting...
ProLynx announces allowance of additional U.S. patent for PLX038, a novel DNA damage response enhancer
10 avr. 2018 09h00 HE
|
ProLynx LLC
SAN FRANCISCO, April 10, 2018 (GLOBE NEWSWIRE) -- Prolynx LLC (San Francisco, CA) announced it received a Notice of Allowance for its DNA damage enhancer PLX038 (PEG~SN-38), currently in Phase 1...
Forecast International Predicts $213 Billion Regional Market Over 15 Years
26 sept. 2017 03h00 HE
|
Forecast International
NEWTOWN, Conn., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Forecast International projects that a total of 5,728 regional aircraft will be produced in the 15-year period from 2017 through 2031, including...
Forecast International Predicts Restrained Growth in Regional Aircraft Market
03 oct. 2013 10h46 HE
|
Forecast International, Inc.
NEWTOWN, Conn., Oct. 3, 2013 (GLOBE NEWSWIRE) -- In Forecast International's new study, "The Market for Regional Transport Aircraft," the Connecticut-based market research firm predicts that 4,035...
Practical Law Company & Goodwin Procter LLP to Present Free Webinar, "Affiliate Transaction Restrictions for Banks: Your Guide to the Requirements"
26 oct. 2011 08h30 HE
|
Practical Law Company
NEW YORK, NY--(Marketwire - Oct 26, 2011) - Recognizing that even seasoned banking and finance attorneys may still struggle to understand affiliate transaction restrictions (ATRs) for banks,...